University of Groningen. Technology in practice Lexmond, Anne
|
|
- Kristina Summers
- 5 years ago
- Views:
Transcription
1 University of Groningen Technology in practice Lexmond, Anne IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2014 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Lexmond, A. (2014). Technology in practice: The importance of matching purpose, patient, and product in pulmonary aerosol delivery. [S.l.]: [S.n.]. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date:
2 CHAPTER 6 THE EFFECT OF A DISPOSABLE EXTENSION MOUTHPIECE ON THE AEROSOL FROM THE REDIHALER Anne J. Lexmond, Paul Hagedoorn, T.Y. Jerôme Appeldoorn, Tamira A.B. Jansman, Henderik W. Frijlink, Anne H. de Boer
3 Chapter 6 ABSTRACT To allow the use of the salbutamol Redihaler by multiple patients as reliever medication during challenge tests in the clinic, a disposable extension mouthpiece with a one-way valve has been developed to prevent exhalation into the device. We investigated whether this mouthpiece affects the aerosol from the Redihaler in terms of its delivered dose and particle size distribution. Single shot impinger measurements and cascade impaction analyses were performed at three different flow rates: 30, 60, and 90 L/min. We found that the extension mouthpiece reduces the delivered dose by about 85% at L/min and by 94% at 30 L/min, leading to the conclusion that 30 L/min is insufficient to open the mouthpiece s valve completely. Furthermore, and as expected, the external piece selectively retains the larger particles from the aerosol, mainly those larger than 3 µm. Although the delivered dose from the Redihaler is greatly reduced by the disposable mouthpiece, comparable results can be found when a standard pressurised metered dose inhaler is used with a valved holding chamber. Therefore, in spite of the high losses, we consider the Redihaler with disposable extension mouthpiece suitable as alternative to the standard reliever medication (pmdi with a VHC), provided that the patient is instructed to inhale moderately forceful to allow proper opening of the valve in the mouthpiece. 130
4 Disposable extension mouthpiece for the Redihaler INTRODUCTION Bronchial challenge tests are widely used for the assessment of bronchial hyperresponsiveness and diagnosis of asthma. Since it is the actual aim of a bronchial challenge test to induce bronchoconstriction, safety is a very important aspect of the test. In order to counteract the bronchoconstriction when necessary (or when the test is completed), reliever medication should be readily available (35). Most often, the bronchodilator salbutamol is given to relieve the mild constriction that usually results from the challenge test. For the salbutamol administration, a pressurised metered dose inhaler (pmdi) combined with a valved holding chamber (VHC) is generally used, which is equipped with a disposable mouthpiece to allow use of the same inhaler by multiple patients. Standard pmdis are actuated by pressing down the canister. Upon actuation, the salbutamol dose is fired into the VHC, from which it can be inhaled in multiple breaths by the patient. In contrast to standard pmdis, the Redihaler pmdi is breath-actuated, i.e. the dose is fired upon inhalation through the pmdi by the patient. This feature may significantly increase both the treatment s efficacy and convenience for use at home, since good actuation-inhalation coordination or the use of a VHC is no longer necessary. For use in the clinic, a disposable patient interface is required, to which end the manufacturer of the Redihaler has developed a disposable mouthpiece. Although in everyday language referred to as a filter mouthpiece by the supplier, this extension part actually contains a one-way valve and not a filter. The valve is meant to prevent breathing into the Redihaler, which would render it unsuitable for use by other patients. The aim of this study was to determine whether the Redihaler with the extension mouthpiece can be a suitable alternative to a standard pmdi with VHC for the delivery of reliever salbutamol in the clinic. We investigated how and to what extent the disposable extension piece affects the performance of the Redihaler by measuring the delivered dose and particle size distribution in the aerosol. 131
5 Chapter 6 MATERIALS AND METHODS Materials Redihaler salbutamol 100 µm and disposable extension mouthpieces from TEVA Pharmaceuticals (Haarlem, The Netherlands) were used in the study. Salbutamol sulphate (Ph. Eur.), provided by DMV Fonterra Excipients (Goch, Germany), was used for preparing a calibration curve for UV analysis. Single shot impinger measurements The single shot impinger is a centrifugal wet particle collector that can be used to determine the dose that is emitted from inhalation devices. Delivered doses from the Redihaler with and without extension mouthpiece were determined at 30, 60, and 90 L/min. In accordance with the European Pharmacopoeia, 4 L of air was drawn through the device to collect one dose, for which 8, 4, and 2.7 s were required at 30, 60, and 90 L/min respectively. The single shot impinger was filled with 10 ml of water and ten doses were collected per measurement. Two series of measurements were conducted, consisting of one measurement without the extension mouthpiece and subsequently five measurements with the extension mouthpiece. Salbutamol deposition in the impinger was determined by UV spectroscopy at 225 nm. Cascade impaction measurements Cascade impaction measurements were performed with the Next Generation Impactor (NGI: Copley Scientific, UK). The NGI was cooled to approximately 5 C in the refrigerator prior to the measurements in accordance with the procedure recommended by Berg et al. for wet aerosols (264). This study also describes that the stage cups of the NGI can be used uncoated, since moist particles do not bounce off once they impact on the surface. The measurements were performed in duplicate at 30, 60, and 90 L/min. Equal to the single shot impinger measurements, 4 L of air was drawn through the device to collect each dose (at 8, 4, and 2.7 s measuring time respectively). Ten and twenty doses were collected per measurement without and with the extension mouthpiece respectively. Salbutamol deposition in the induction port and stage cups was determined by UV spectroscopy at 225 nm. 132
6 Disposable extension mouthpiece for the Redihaler Data presentation and analysis The delivered doses without extension mouthpiece are expressed as percentage of the label claim (100 µg). To allow for comparison of the effect of the extension mouthpiece on the delivered dose per flow rate, the delivered doses found with the extension mouthpiece were calculated as percentage of the delivered dose without mouthpiece measured at the beginning of the series. Unpaired two-sided Student s t tests were performed to compare the delivered doses at the different flow rates. Probability values (p) < 0.05 were considered statistically significant. Cumulative mass fractions deposited on the NGI stages were expressed as percentage of the label claim and plotted as function of the stage cut-off values corresponding with the flow rates adjusted. The relationships obtained were used to calculate sub fractions <1, 1 3, and 3 5 µm respectively by linear interpolation. RESULTS AND DISCUSSION Delivered dose with and without extension mouthpiece Although the inhaler was handled according to the instructions (vigorously shaken before use and discarding of the first doses), the delivered dose from the Redihaler without extension mouthpiece varied from 65 to 95% for the individual measurements. On average, we found delivered doses of 76, 70, and 95% at 30, 60, and 90 L/ min, respectively, which suggests that there is no clear relationship between flow rate and delivered dose. However, there appeared to be an inverse relation between the delivered dose and the number of doses left in the inhaler, but this was not systematically investigated in this study. Figure 6-1 shows the delivered dose from the Redihaler when the extension mouthpiece is used as percentage of the delivered dose without mouthpiece. A strong reduction was found at all flow rates, which was visually verified by deposition of powder on the inside of the extension mouthpiece. The reduction was most pronounced at 30 L/min, at which only 6% of the delivered dose relative to the dose without extension piece was recovered. This recovery was significantly lower than those at 60 and 90 L/ min (p < ). Between the two highest flow rates, no significant difference was found due to the large variation in the results (p = 0.069). 133
7 Chapter 6 20 Delivered dose (%) Flow rate (L/min) Figure 6-1. The delivered dose from the Redihaler when the extension mouthpiece is used expressed as percentage of the delivered dose without extension mouthpiece. The lower delivered dose found at a flow rate of 30 L/min can be attributed to the design of the extension mouthpiece. The valve within the mouthpiece appears to require a certain minimal airflow rate to open sufficiently wide for aerosol passage. A flow rate of 30 L/min does not suffice in this respect. Since no difference in delivered dose was found between 60 and 90 L/min, the threshold flow rate for complete opening the valve completely is expected to be anywhere between 30 and 60 L/min, but even after complete opening a substantial portion of the delivered dose is retained in the extension piece. Aerodynamic size distribution of the aerosol Figure 6-2 shows the fine particle fractions < 5 µm (FPF) of the aerosols with and without extension divided into three subclasses: < 1 µm, 1 3 µm, and 3 5 µm. At all flow rates, the diminishing effect of the extension mouthpiece on the FPF is apparent. Without extension mouthpiece, FPFs were 45, 48, and 37% of the label claim at 30, 60, and 90 L/min respectively. Comparing these values to the delivered doses found with the impinger, it can be seen that maximally 50% of the delivered dose is within the desired size range for good lung deposition. Remarkable is the lower fraction deposited at 90 L/min using the NGI compared to the impinger measurements. A reason for this might be that the higher airflow rate led to more turbulence in the NGI, thereby resulting in reduced deposition on the stages (265). 134
8 Disposable extension mouthpiece for the Redihaler Fraction of label claim (%) without filter with filter < < < L/min 60 L/min 90 L/min Particle diameter (µm) Figure 6-2. The fine particle fractions of the aerosols from the Redihaler with and without extension mouthpiece, expressed as percentage of the label claim (100 µg). The FPFs with extension mouthpiece were 7, 10, and 13% of the label claim at 30, 60, and 90 L/min respectively. These values are comparable to the delivered doses found with the impinger. Additionally, Figure 6-2 shows that the extension piece selectively retains the largest particles. This finding can also be explained by the design of the extension piece. The particles emitted from the inhaler have to follow the change in airflow direction when they pass through the valve. The larger the particles are, the larger is their inertia, and the more likely they impact on the valve. Implications of using the extension mouthpiece We have shown that using the extension mouthpiece greatly reduces the dose that is delivered by the Redihaler. Especially at a flow rate of 30 L/min, only a very limited fraction of the aerosol was delivered from the mouthpiece. The Redihaler requires a flow rate of 20 L/min to fire its dose and the manufacturer of the Redihaler advises to inhale slowly through the device (266). When operated without extension mouthpiece, this advice should be heeded, since the higher the flow rate is, the more deposition occurs in the mouth and throat region. However, when the extension mouthpiece is used, inhaling with such low flow rates leads to insufficient opening of the valve, and hence, to insufficient release of the aerosol. In addition, the disposable mouthpiece retains the aerosol selectively as only a small 135
9 Chapter 6 fraction larger than 3 µm was found to pass through the valve. Blocking the particles larger than 5 µm can be considered a useful feature of the extension mouthpiece, since these particles would otherwise deposit mainly in the mouth and throat and are therefore not desired. In contrast, the fraction 3 5 µm is highly wanted because this fraction is mainly deposited in the conducting airways, where constriction of the smooth muscle tissue is the main cause for the bronchoconstriction during a bronchial challenge test. Retaining this fraction may thus render the Redihaler less effective in counteracting breathlessness after challenge. It should be noted that the Redihaler in combination with the extension mouthpiece is offered as an alternative to a standard pmdi in combination with a VHC. Hence, for its effectiveness it should be compared to this combination rather than to a pmdi alone. In terms of clinical effectiveness, no difference was found between four times 100 µg salbutamol administered by the combination of Redihaler and extension mouthpiece or Ventolin and Nebuhaler with a disposable valve (267). The comparable response to the two treatments may on the one hand be the result of the abundant dose of 400 µg, of which a sufficiently large fraction within the desired size range remains for deposition in the target area for patients to recover to baseline. On the other hand, VHCs are also known to retain a significant part of the aerosol, which depending on the material of which the VHC is made and the environmental conditions can become as high as 90 95% too (268,269). CONCLUSION Based on the combined results of this in vitro characterisation study with the clinical response data of Ruberg et al. (267), the salbutamol Redihaler (100 µg) with extension mouthpiece appears to be an suitable alternative to the standard rescue treatment after bronchial challenge, but only if the patient is instructed to inhale moderately forceful to allow complete opening of the valve. 136
10 Disposable extension mouthpiece for the Redihaler 137
11
Citation for published version (APA): Westerman, E. M. (2009). Studies on antibiotic aerosols for inhalation in cystic fibrosis s.n.
University of Groningen Studies on antibiotic aerosols for inhalation in cystic fibrosis Westerman, Elisabeth Mechteld IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF)
More informationEquivalence Evaluation of Valved Holding Chambers (VHCs) with Albuterol Pressurized Metered Dose Inhaler (pmdi)
Respiratory Drug Delivery Europe 2017 Nagel and Suggett Equivalence Evaluation of Valved Holding Chambers (VHCs) with Albuterol Pressurized Metered Dose Inhaler (pmdi) Mark W. Nagel and Jason A. Suggett
More informationUnderstanding cascade impaction and its importance for inhaler testing
Understanding cascade impaction and its importance for inhaler testing Mark Copley, Technical Sales Manager Inhalation product development is an important area of activity for the pharmaceutical sector.
More informationCOMPARISON OF THE RESPIRABLE FRACTION FROM THREE DIFERENT DPI DEVICES
COMPARISON OF THE RESPIRABLE FRACTION FROM THREE DIFERENT DPI DEVICES Miriam Sanz Cermeño and Helena Maria Cabral Marques UCTF, Faculdade de Farmácia, Universidade de Lisboa, PORTUGAL 1. Introduction Inhalation
More informationCaption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31).
Product-specific FDA guidance, and product-specific pharmacopeial monographs, point to the use of test equipment, some of which isn t included in the general USP/Ph. Eur. chapters for orally inhaled products
More informationCharacterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing
INSTRUMENTATION» Characterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing Mark Copley Director Copley Scientific The recent introduction
More informationCitation for published version (APA): Koning, J. P. D. (2001). Dry powder inhalation: technical and physiological aspects, prescribing and use s.n.
University of Groningen Dry powder inhalation Koning, Johannes Petrus de IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the
More informationInhalation Product Research at FDA
Inhalation Product Research at FDA Changning Guo Ph. D., Chemist Division of Pharmaceutical Analysis FDA/CDER/OPS/OTR 2016 GPhA CMC workshop, May 17, 2016 Disclaimer: This presentation reflects the views
More informationUniversity of Groningen. BNP and NT-proBNP in heart failure Hogenhuis, Jochem
University of Groningen BNP and NT-proBNP in heart failure Hogenhuis, Jochem IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationGo With the Flow REGULATORY LANDSCAPE. Mark Copley at Copley Scientific
Go With the Flow Image: Guzel Studio shutterstock.com Increasing global requirements for efficacious, inexpensive products to treat respiratory illnesses are driving the development of inhaled generics.
More informationEffect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics
Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics Ariel Berlinski MD and David Pennington BACKGROUND: Albuterol hydrofluoroalkane
More informationI. Subject: Medication Delivery by Metered Dose Inhaler (MDI)
I. Subject: Medication Delivery by Metered Dose Inhaler (MDI) II. Policy: Aerosol medication administration by metered dose inhaler will be performed upon a physician's order by Respiratory Therapy personnel.
More informationIMPROVING THE REALISM AND RELEVANCE OF MOUTH-THROAT MODELS FOR INHALED PRODUCT TESTING
IMPROVING THE REALISM AND RELEVANCE OF MOUTH-THROAT MODELS FOR INHALED PRODUCT TESTING In this piece, Mark Copley, Sales Director of Copley Scientific, provides some background on mouth-throat models for
More informationCitation for published version (APA): Weert, E. V. (2007). Cancer rehabilitation: effects and mechanisms s.n.
University of Groningen Cancer rehabilitation Weert, Ellen van IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document
More informationIVIVC in Pediatric OIPs
IPAC-RS/UF Orlando Conference 2014 March 20, 2014 IVIVC in Pediatric OIPs Herbert Wachtel Declaration of Conflicts of Interest H. Wachtel is employee of Boehringer Ingelheim Pharma GmbH & Co. KG, Germany.
More informationAssessing the role of breathing simulators in OIP testing
As first AppeAred in Inhalation April 2014 www.inhalationmag.com Assessing the role of breathing simulators in OIP testing Exploring how the application of patient-representative inhalation profiles can
More informationUniversity of Groningen. Optimisation of dry powder inhalation Boer, Anne Haaije de
University of Groningen Optimisation of dry powder inhalation Boer, Anne Haaije de IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationRespiratory Therapy. Medical/Scientific/General Background
Respiratory Therapy Medical/Scientific/General Background Marketing Europe Dr. Rainer Jakobs PMM Europe 1 Dr. Rainer Jakobs, PMM Europe RT Medical/Scientific/General Background 2 Dr. Rainer Jakobs, PMM
More informationHow to use your QVAR RediHaler (beclomethasone dipropionate)
(beclomethasone dipropionate) 40 mcg, 80 mcg What is my prescription? Special instructions Take every day to control your symptoms. Rinse mouth thoroughly with water and spit after each use. What can I
More informationDry Powder Inhaler. Developing an Efficient. 3M Conix DPI. White Paper / Spring Proven Solutions that Enable Your Success
3M Drug Delivery Systems Developing an Efficient Dry Powder Inhaler 3M Conix DPI White Paper / Spring 2011 Proven Solutions that Enable Your Success Introduction introduction Inhalation drug delivery has
More information21/03/2011 AEROSOL DEPOSITION AND THE ASSESSMENT OF PULMONARY DRUG DELIVERY. Fundamentals of aerosols
AEROSOL DEPOSITION AND THE ASSESSMENT OF PULMONARY DRUG DELIVERY AEROSOL DEPOSITION AND THE ASSESSMENT OF PULMONARY DRUG DELIVERY Steve Newman Scientific Consultant Norfolk, UK steve.newman@physics.org
More informationPerceptual reasons for resistance to change in the emergency department use of holding chambers for children with asthma
Perceptual reasons for resistance to change in the emergency department use of holding chambers for children with asthma The need for sufficient human resources and deal with the perceived increase in
More informationDevice Design Similarity
Device Design Similarity Dave Parkins Director DPI Product Development PQRI Workshop on Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products. Bethesda March 9-10, 2009 Device Similarity
More informationPET Imaging of Mild Traumatic Brain Injury and Whiplash Associated Disorder Vállez García, David
University of Groningen PET Imaging of Mild Traumatic Brain Injury and Whiplash Associated Disorder Vállez García, David IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationCLINICAL RELEVANCE OF IN VITRO PARTICLE SIZING DATA. Steve Newman, PhD Nottingham, UK November 2006
IPAC-RS Conference 6-8 November 2006 CLINICAL RELEVANCE OF IN VITRO PARTICLE SIZING DATA Steve Newman, PhD Nottingham, UK November 2006 IPAC-RS Conference 6-8 November 2006 1 EFFECT OF PARTICLE SIZE ON
More informationCAPSULE-BASED DRY POWDER INHALERS, AN OPTIMAL SOLUTION FOR DIFFERENT INSPIRATIONAL RATES
xxx Qualicaps CAPSULE-BASED DRY POWDER INHALERS, AN OPTIMAL SOLUTION FOR DIFFERENT INSPIRATIONAL RATES There is a wide range of devices available to deliver inhalation therapies, but there is increasing
More informationUniversity of Groningen. Symptomatic and asymptomatic airway hyperresponsiveness Jansen, Desiree
University of Groningen Symptomatic and asymptomatic airway hyperresponsiveness Jansen, Desiree IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationUniversity of Groningen. Real-world influenza vaccine effectiveness Darvishian, Maryam
University of Groningen Real-world influenza vaccine effectiveness Darvishian, Maryam IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationInhalation devices, proper technique and cleaning
Preventing Your Symptoms and Taking Your Medications Inhalation devices, proper technique and cleaning Knowing how to use your medications properly is important because inhaled drugs are meant to get directly
More informationUniversity of Groningen. Diminished ovarian reserve and adverse reproductive outcomes de Carvalho Honorato, Talita
University of Groningen Diminished ovarian reserve and adverse reproductive outcomes de Carvalho Honorato, Talita IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationImproving quality of care for patients with ovarian and endometrial cancer Eggink, Florine
University of Groningen Improving quality of care for patients with ovarian and endometrial cancer Eggink, Florine IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationPulmonary deposition of inhaled drugs
Pulmonary deposition of inhaled drugs Federico Lavorini Dept. Experimental and Clinical Medicine Careggi University Hospital Florence - Italy Presenter Disclosures F.L. has received in the last 5 years
More informationMajor role of the extracellular matrix in airway smooth muscle phenotype plasticity Dekkers, Bart
University of Groningen Major role of the extracellular matrix in airway smooth muscle phenotype plasticity Dekkers, Bart IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationUsing an Inhaler and Nebulizer
Using an Inhaler and Nebulizer Introduction An inhaler is a handheld device that is used to deliver medication directly to your airways. A nebulizer is an electric or battery powered machine that turns
More informationDelay Between Actuation and Shaking of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler
Delay Between Actuation and Shaking of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler Ariel Berlinski MD, Dirk von Hollen, John N Pritchard PhD, and Ross HM Hatley PhD BACKGROUND: Inhaled
More informationAEROSOL THERAPY: THE PRACTICALITIES
AEROSOL THERAPY: THE PRACTICALITIES Lester I. Harrison, PhD Section Head, Clinical Pharmacokinetics, 3M Pharmaceuticals, 3M Center 270-3S-05, St. Paul, MN, USA 55144 liharrison@mmm.com Introduction: Horses,
More informationEPAG Sponsored Workshop on Abbreviated Impactor Measurement (AIM) and Efficient Data Analysis (EDA) Concepts in Inhaler Testing. Overview of AIM EDA
EPAG Sponsored Workshop on Abbreviated Impactor Measurement (AIM) and Efficient Data Analysis (EDA) Concepts in Inhaler Testing Overview of AIM EDA Jolyon Mitchell 1 and Mark Copley 2 1 Trudell Medical
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 120 No 1267 ISSN 1175 8716 Is Salamol less effective than Ventolin? A randomised, blinded, crossover study in New Zealand Catherina L Chang, Manisha Cooray, Graham Mills,
More informationUse of Math Modelling to Understand Delivery of Biopharmaceutical Molecules to the Lung
Use of Math Modelling to Understand Delivery of Biopharmaceutical Molecules to the Lung Nia Stevens 9 th November 2016 Thanks to Richard Kaye, James Mitchell, Dave Prime at GSK Bahman Asgharian and Owen
More informationDelivery of Iloprost Inhalation Solution With the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery Systems: An In Vitro Study
Delivery of Iloprost Inhalation Solution With the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery Systems: An In Vitro Study Robert E Van Dyke MSc and Kurt Nikander BACKGROUND: Iloprost (Ventavis)
More informationAppendix M: Device Technique
Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Appendix M: Device Technique Medications: Inhalation Devices Medications come in many forms.
More informationQ. What are metered-dose inhalers? A. These are devices that dispense medicines directly into the lungs, in the form of a mist or aerosol in a
1 2 Q. What are metered-dose inhalers? A. These are devices that dispense medicines directly into the lungs, in the form of a mist or aerosol in a specific dosage. In an MDI, the medicine is suspended
More informationPharmacoeconomic analysis of proton pump inhibitor therapy and interventions to control Helicobacter pylori infection Klok, Rogier Martijn
University of Groningen Pharmacoeconomic analysis of proton pump inhibitor therapy and interventions to control Helicobacter pylori infection Klok, Rogier Martijn IMPORTANT NOTE: You are advised to consult
More informationCitation for published version (APA): Otten, M. P. T. (2011). Oral Biofilm as a Reservoir for Antimicrobials Groningen: University of Groningen
University of Groningen Oral Biofilm as a Reservoir for Antimicrobials Otten, Marieke Petronella Theodora IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish
More informationMDI. Recommended Equipment
1 x DUSA for MDIs (Silicone Seals) 1 x Base Plate MDI 1 x DUSA for MDIs (Silicone Seals) 9 x Spare Collection Tubes for MDIs 18 x Spare Rinsing Caps for MDIs 1 x Stand for 10 Collection Tubes 1 x Waste
More informationBrain-inspired computer vision with applications to pattern recognition and computer-aided diagnosis of glaucoma Guo, Jiapan
University of Groningen Brain-inspired computer vision with applications to pattern recognition and computer-aided diagnosis of glaucoma Guo, Jiapan IMPORTANT NOTE: You are advised to consult the publisher's
More informationPatricia KP Burnell Inhalation Product Development
Patricia KP Burnell Inhalation Product Development Inhaled products: types, development The critical parameters In-vitro testing Ex-vivo testing What dose? Product Development: drug medicine Safety and
More informationPatient. Device Clinician. Safety & efficacy
Patient Device Clinician Formulation Safety & efficacy 1. Modified from Daley-Yates et al., Expert Opin. Drug Deliv. 2011: 8(10):1297-1308 2. Modified from Laube et al., Eur Respir J 2011; 37: 1308 1331
More informationIt is recommended that a mask and protective eyewear be worn when providing care to a patient with a cough
UNIVERSITY HEALTH NETWORK POLICY #: PAGE 1 OF 7 POLICY AND PROCEDURE MANUAL: RESPIRATORY THERAPY DEPT PATIENT CARE SECTION ORIGINAL DATE: 04/03 ISSUED BY: SITE LEADER APPROVED BY: Infection Prevention
More informationUniversity of Groningen. Optimisation of dry powder inhalation de Boer, Anne
University of Groningen Optimisation of dry powder inhalation de Boer, Anne IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS
European Medicines Agency Inspections London, 16 February 2005 Doc Ref.: EMEA/CHMP/QWP/49313/2005 corr. COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF
More informationASTHMA POLICY KYABRAM P-12 COLLEGE
Asthma Policy ASTHMA POLICY KYABRAM P-12 COLLEGE THE VICTORIAN SCHOOLS ASTHMA POLICY 1. ASTHMA AWARENESS As asthma can affect up to one in five children and one in ten adults, it is important for teachers
More informationUniversity of Groningen. The Economics of assisted reproduction Connolly, Mark Patrick
University of Groningen The Economics of assisted reproduction Connolly, Mark Patrick IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationMisty Max 10 nebulizer
AirLife brand Misty Max 10 nebulizer Purpose Introduction Delivery of nebulized medication to the lungs is a complex process dependant upon a variety of clinical and device-related variables. Patient breathing
More informationUniversity of Groningen. Acantholysis in pemphigus van der Wier, Gerda
University of Groningen Acantholysis in pemphigus van der Wier, Gerda IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the
More informationGoal-oriented hemodynamic treatment in high-risk surgical patients Sonneveld, Johan Pieter Cornelis
University of Groningen Goal-oriented hemodynamic treatment in high-risk surgical patients Sonneveld, Johan Pieter Cornelis IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationInvacare Aerosol Products. Stratos Aerosol Compressors Nebulizers Asthma Management
Invacare Aerosol Products Stratos Aerosol Compressors Nebulizers Asthma Management Invacare Aerosol Products Invacare is proud to offer an updated aerosol product line that includes the Stratos Compact,
More informationRespiratory. Martin Jetzer DDL27 Edinburgh December 2016
Respiratory Investigating the Effect of the Force Control Agent Magnesium Stearate in Fluticasone Propionate Dry Powder Inhaled Formulations with Single Particle Aerosol Mass Spectrometry Martin Jetzer
More informationCitation for published version (APA): Tielliu, I. F. J. (2010). Endovascular repair of peripheral artery aneurysms Groningen: s.n.
University of Groningen Endovascular repair of peripheral artery aneurysms Tielliu, Ignace François Jacques IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish
More informationUniversity of Groningen. Non-alcoholic fatty liver disease Sheedfar, Fareeba
University of Groningen Non-alcoholic fatty liver disease Sheedfar, Fareeba IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationNEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS
NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS Douglas S. Gardenhire, Ed.D, RRT-NPS MODULE 1 Manipulate Small Volume Nebulizers by Order or Protocol 1 Objectives for Module 1 At the end of
More informationIn vitro studies on the cytoprotective properties of Carbon monoxide releasing molecules and N-acyl dopamine derivatives Stamellou, Eleni
University of Groningen In vitro studies on the cytoprotective properties of Carbon monoxide releasing molecules and N-acyl dopamine derivatives Stamellou, Eleni IMPORTANT NOTE: You are advised to consult
More informationDevelopment of patient centered management of asthma and COPD in primary care Metting, Esther
University of Groningen Development of patient centered management of asthma and COPD in primary care Metting, Esther IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF)
More informationGMMMG Asthma Formulary Inhaler Options August 2017
Regular Preventer Beclometasone Beclometasone Beclometasone Brand name Qvar Easi-Breathe Clenil Modulite Easyhaler Device MDI MDI DPI Strengths 50 microgram 100 microgram 200 microgram Adult asthma 2 inhalations
More informationHow can I benefit most from my COPD medications?
Fact Sheet: COPD Medications and Delivery Devices How can I benefit most from my COPD medications? COPD medications can improve your symptoms. By taking the right medication at the right time, you can
More informationOPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER
OPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER US FDA guidance for the in vitro demonstration of bioequivalence in a generic nebuliser directly references
More informationCOPD Device Workshop. Summary. Role of inhaler device in COPD. Why use inhaler device in COPD?
Part 1 Role of inhaler device in COPD COPD Device Workshop Dr Philip Lee Respiratory and Sleep Physician St George Hospital, Sydney Part 2 Part 3 Part 4 Incorrect inhaler technique-adverse clinical outcomes
More informationMetered Dose Inhalers with Valved Holding Chamber: A Pediatric Hospital Experience
Metered Dose Inhalers with Valved Holding Chamber: A Pediatric Hospital Experience 8th Annual North Regional Respiratory Care Conference Minnesota & Wisconsin Societies for Respiratory Care Mayo Civic
More informationInsulin sensitivity of hepatic glucose and lipid metabolism in animal models of hepatic steatosis Grefhorst, Aldo
University of Groningen Insulin sensitivity of hepatic glucose and lipid metabolism in animal models of hepatic steatosis Grefhorst, Aldo IMPORTANT NOTE: You are advised to consult the publisher's version
More informationUniversity of Groningen
University of Groningen Physiology, Psychoacoustics and Cognition in Normal and Impaired Hearing Preface van Dijk, Pim; Bakent, Deniz; de Kleine, Emile; Gaudrain, Etienne; Wagner, Anita; Lanting, Cornelis;
More informationUniversity of Groningen
University of Groningen Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization Brandenburg, Boerries; Koudstaal, Wouter; Goudsmit, Jaap; Klaren, Vincent; Tang, Chan; Bujny, Miriam V.; Korse,
More informationThe influence of lactose particle size on dry powder inhalation performance
The influence of lactose particle size on dry powder inhalation performance MCC Starch Lactose Inhalation Superdisintegrants 1 Introduction In most dry powder inhalation (DPI) formulations carriers are
More informationUniversity of Groningen. Carcinoembryonic Antigen (CEA) in colorectal cancer follow-up Verberne, Charlotte
University of Groningen Carcinoembryonic Antigen (CEA) in colorectal cancer follow-up Verberne, Charlotte IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish
More informationPREMIXES FOR MEDICATED FEEDING STUFFS FOR VETERINARY USE. Praeadmixta ad alimenta medicata ad usum veterinarium. Effervescent powders
Preparations for inhalation administered in or with water or another suitable liquid. They may also be swallowed directly. They are presented as single-dose or multidose preparations. Where applicable,
More informationRole of multidrug resistance-associated protein 1 in airway epithelium van der Deen, Margaretha
University of Groningen Role of multidrug resistance-associated protein 1 in airway epithelium van der Deen, Margaretha IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF)
More informationSorting and trafficking of proteins in oligodendrocytes during myelin membrane biogenesis Klunder, Lammert
University of Groningen Sorting and trafficking of proteins in oligodendrocytes during myelin membrane biogenesis Klunder, Lammert IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationTesting Inhaled Generics
Generic Bioequivalence Testing Inhaled Generics By Mark Copley at Copley Scientific New product-specific FDA guidance and USP monographs support the development of popular inhaled products. This article
More informationTunable Hydrophobicity in DNA Micelles Anaya, Milena; Kwak, Minseok; Musser, Andrew J.; Muellen, Klaus; Herrmann, Andreas; Müllen, Klaus
University of Groningen Tunable Hydrophobicity in DNA Micelles Anaya, Milena; Kwak, Minseok; Musser, Andrew J.; Muellen, Klaus; Herrmann, Andreas; Müllen, Klaus Published in: Chemistry DOI: 10.1002/chem.201001816
More informationUniversity of Groningen. Leven na een beroerte Loor, Henriëtte Ina
University of Groningen Leven na een beroerte Loor, Henriëtte Ina IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document
More informationThe role of the general practitioner in the care for patients with colorectal cancer Brandenbarg, Daan
University of Groningen The role of the general practitioner in the care for patients with colorectal cancer Brandenbarg, Daan IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationYear in review. Vit Perlik Director of Regulatory Science and Clinical Development
Year in review Vit Perlik Director of Regulatory Science and Clinical Development Content Year in review Covering September 2013 to September 2014 Where the regulation goes selection of events for illustration
More informationBeclometasone dipropionate (BDP) Prophylactic management of mild, moderate or severe asthma in adults
CLENIL MODULITE Beclometasone dipropionate (BDP) Prophylactic management of mild, moderate or severe asthma in adults Corticosteroids for the treatment of chronic asthma in adults and children aged 12
More informationThe effect of different coating materials on the prevention of powder bounce in the next generation impactor
Research in Pharmaceutical Sciences, June 2018; 13(3): 283-287 Received: June 2017 Accepted: December 2017 School of Pharmacy & Pharmaceutical Sciences Isfahan University of Medical Sciences Short Communication
More informationAn update on inhalation devices
OPTIMIZING INHALED DRUG DELIVERY An update on inhalation devices Contents 1. Introduction...1 2. History of spacers... 1 3. Working of a spacer... 2 4. Advantages of spacer devices... 3 5. Who should
More informationUniversity of Groningen. ADHD and atopic diseases van der Schans, Jurjen
University of Groningen ADHD and atopic diseases van der Schans, Jurjen IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the
More informationUniversity of Groningen. The Groningen Identity Development Scale (GIDS) Kunnen, Elske
University of Groningen The Groningen Identity Development Scale (GIDS) Kunnen, Elske IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More information2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus
2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus Patient Perspective Alpha-1 1 Foundation John W. Walsh Patient Focus Personal perspective Challenges and lessons Importance
More informationUniversity of Groningen. Soft tissue development in the esthetic zone Patil, Ratnadeep Chandrakant
University of Groningen Soft tissue development in the esthetic zone Patil, Ratnadeep Chandrakant IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationUniversity of Groningen. Transdermal delivery of anticholinergic bronchodilators Bosman, Ingrid Jolanda
University of Groningen Transdermal delivery of anticholinergic bronchodilators Bosman, Ingrid Jolanda IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to
More information8/13/11. RSPT 1410 Humidity & Aerosol Therapy Part 3. Humidification Equipment. Aerosol Therapy
1 RSPT 1410 Humidity & Aerosol Therapy Part 3 Wilkins: Chapter 35, p. 775-799 Cairo: Chapter 4, p. 88-143 2 Humidification Equipment A humidifier is a device that adds molecular liquid (e.g. water vapor)
More informationUniversity of Groningen. Medication use for acute coronary syndrome in Vietnam Nguyen, Thang
University of Groningen Medication use for acute coronary syndrome in Vietnam Nguyen, Thang IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationApoptosis in (pre-) malignant lesions in the gastro-intestinal tract Woude, Christien Janneke van der
University of Groningen Apoptosis in (pre-) malignant lesions in the gastro-intestinal tract Woude, Christien Janneke van der IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationInhalation Therapy. Inhalation Therapy
Matching Device and Patient Matching Patient to the Device Søren Pedersen University of Southern Denmark Kolding Hospital Anatomical factors (age) Training and education Delivered dose Psycomotor skills
More informationIn Vitro Evaluation of Positive Expiratory Pressure Devices Attached to Nebulizers
In Vitro Evaluation of Positive Expiratory Pressure Devices Attached to Nebulizers Ariel Berlinski MD BACKGROUND: Patients with cystic fibrosis perform airway clearance techniques and receive nebulized
More informationThe role of the general practitioner during treatment and follow-up of patients with breast cancer Roorda-Lukkien, Carriene
University of Groningen The role of the general practitioner during treatment and follow-up of patients with breast cancer Roorda-Lukkien, Carriene IMPORTANT NOTE: You are advised to consult the publisher's
More informationProduct Guide. MSP Corporation Rice Creek Parkway, Suite 300. Shoreview, Minnesota 55126, U.S.A. Phone: Fax:
Product Guide inhalertesting MSP Corporation 5910 Rice Creek Parkway, Suite 300 Shoreview, Minnesota 55126, U.S.A. Phone: 651.287.8100 Fax: 651.287.8140 sales@mspcorp.com www.mspcorp.com About This Guide
More informationCascade Impactor Study Comparing the Amsino OneMask Oxygen Mask and Predicate Mask from Hudson RCI on a Human Model
(p) 93-850-6630 (f) 93-850-6635 Cascade Impactor Study Comparing the Amsino OneMask Oxygen Mask and Predicate Mask from Hudson RCI on a Human Model Abstract This in vitro study compares drug delivery efficiencies
More informationUniversity of Groningen. Physical activity and cognition in children van der Niet, Anneke Gerarda
University of Groningen Physical activity and cognition in children van der Niet, Anneke Gerarda IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationVentamol CFC-Free 100 micrograms, Pressurised Inhalation, Suspension (Salbutamol)
Ventamol CFC-Free 100 micrograms, Pressurised Inhalation, Suspension (Salbutamol) For inhalation use Important: Read instructions carefully Wash your inhaler once a week and allow to dry What you need
More informationPathophysiology and management of hemostatic alterations in cirrhosis and liver transplantation Arshad, Freeha
University of Groningen Pathophysiology and management of hemostatic alterations in cirrhosis and liver transplantation Arshad, Freeha IMPORTANT NOTE: You are advised to consult the publisher's version
More information